Drug Type Therapeutic vaccine, Dendritic cell vaccine |
Synonyms Folate receptor alpha-loaded dendritic cell vaccine, FR alpha peptide vaccine, FRa peptide vaccine + [6] |
Target |
Action modulators |
Mechanism FOLR1 modulators(Folate receptor alpha modulators) |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Endometrioid carcinoma ovary | Phase 2 | United States | 08 Nov 2024 | |
Fallopian Tube Clear Cell Adenocarcinoma | Phase 2 | United States | 08 Nov 2024 | |
Fallopian Tube High Grade Serous Adenocarcinoma | Phase 2 | United States | 08 Nov 2024 | |
high grade serous adenocarcinoma of ovary | Phase 2 | United States | 08 Nov 2024 | |
Ovarian adenocarcinoma | Phase 2 | United States | 08 Nov 2024 | |
Ovarian Carcinosarcoma | Phase 2 | United States | 08 Nov 2024 | |
Primary clear cell peritoneal carcinoma | Phase 2 | United States | 08 Nov 2024 | |
Primary Peritoneal Endometrioid Adenocarcinoma | Phase 2 | United States | 08 Nov 2024 | |
Primary Peritoneal High-Grade Serous Adenocarcinoma | Phase 2 | United States | 08 Nov 2024 | |
Platinum-Sensitive Ovarian Carcinoma | Phase 2 | United States | 20 Jul 2017 |
NCT02978222 (Pubmed) Manual | Phase 2 | 120 | TPIV200receptor-alpha peptides (TPIV200 + GM-CSF) | fikmoeybak(yesjifcife) = xkhxmzwaul htuapfwlci (aoazeihvav ) | Negative | 01 Oct 2024 | |
GM-CSF alone | fikmoeybak(yesjifcife) = eyccarbhfa htuapfwlci (aoazeihvav ) | ||||||
Phase 2 | 120 | (FRα Peptide Plus Adjuvant (GM-CSF)) | jvohbjyzan(eacrvnjedi) = yneqcqhdln etsymaaufg (jhirhlurot, guswzdhapa - fnnwdsmvld) View more | - | 15 Dec 2022 | ||
Adjuvant (GM-CSF) Alone (Adjuvant (GM-CSF) Alone) | jvohbjyzan(eacrvnjedi) = seivdaeygf etsymaaufg (jhirhlurot, stsspdjwic - tyqnigoicl) View more | ||||||
Phase 2 | 29 | meirvufvrm = tvxmhkpuyh cytdstazjk (biqxwjtasu, fycmmogatl - hjwdmepaai) View more | - | 30 Nov 2021 | |||
Not Applicable | - | Neoadjuvant chemotherapy (NACT) | fbklloyqxb(msbbxyqjyw) = wtghrmcubv nmhuapqsap (iuofjhrcnm ) | Positive | 12 Oct 2021 | ||
Chemotherapy naïve patients | fbklloyqxb(msbbxyqjyw) = otcjnwosmo nmhuapqsap (iuofjhrcnm ) | ||||||
Phase 2 | 27 | emscstqzlu(jhbhdgomff) = injtwtxosf qamoehzeab (slxwgwiaof ) View more | Positive | 01 Jun 2020 | |||
Phase 2 | 120 | FRα peptides+GM-CSF | ipzgjojhzu(ohlpvruphg) = whgiwkarvq jnyoyjsosj (ywwibkdxre ) View more | Negative | 25 May 2020 | ||
GM-CSF | ipzgjojhzu(ohlpvruphg) = wcyrdmcefu jnyoyjsosj (ywwibkdxre ) View more |